Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oncogenes, Fusion Genes and Tumor Suppressor Genes

Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα

Abstract

The transcription factor C/EBPα (CEBPA) is a key player in granulopoiesis and leukemogenesis. We have previously reported the interaction of C/EBPα with other proteins (utilizing mass spectrometry) in transcriptional regulation. In the present study, we characterized the association of the MYST domain histone acetyltransferase Tat-interactive protein (TIP) 60 (HTATIP) with C/EBPα. We show in pull-down and co-precipitation experiments that C/EBPα and HTATIP interact. A chromatin immunoprecipitation (ChIP) and a confirmatory Re-ChIP assay revealed in vivo occupancy of the C/EBPα and GCSF-R promoter by HTATIP. Reporter gene assays showed that HTATIP is a co-activator of C/EBPα. The co-activator function of HTATIP is dependent on its intact histone acetyltransferase (HAT) domain and on the C/EBPα DNA-binding domain. The resulting balance between histone acetylation and deacetylation at the C/EBPα promoter might represent an important mechanism of C/EBPα action. We observed a lower expression of HTATIP mRNA in undifferentiated U937 cells compared to retinoic acid-induced differentiated U937 cells, and correlated expression of CEBPA and HTATIP mRNA levels were observed in leukemia samples. These findings point to a functional synergism between C/EBPα and HTATIP in myeloid differentiation and suggest that HTATIP might be an important player in leukemogenesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Rosmarin AG, Yang Z, Resendes KK . Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp Hematol 2005; 33: 131–143.

    Article  CAS  PubMed  Google Scholar 

  2. Mueller BU, Pabst T . C/EBPalpha and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006; 13: 7–14.

    Article  PubMed  Google Scholar 

  3. Lane MD, Tang QQ, Jiang MS . Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 1999; 266: 677–683.

    Article  CAS  PubMed  Google Scholar 

  4. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG . Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 1997; 94: 569–574.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Pabst T, Mueller BU, Harakawa N, Schoch C, Haferlach T, Behre G et al. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 2001; 7: 444–451.

    Article  CAS  PubMed  Google Scholar 

  6. Muller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A . Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways. Proc Natl Acad Sci USA 1999; 96: 7276–7281.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Trivedi AK, Bararia D, Christopeit M, Peerzada AA, Singh SM, Kieser A et al. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination. Oncogene 2007; 26: 1789–1801.

    Article  CAS  PubMed  Google Scholar 

  8. Zada AA, Pulikkan JA, Bararia D, Geletu M, Trivedi AK, Balkhi MY et al. Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Leukemia 2006; 20: 2137–2146.

    Article  CAS  PubMed  Google Scholar 

  9. Reddy VA, Iwama A, Iotzova G, Schulz M, Elsasser A, Vangala RK et al. Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions. Blood 2002; 100: 483–490.

    Article  CAS  PubMed  Google Scholar 

  10. Rangatia J, Vangala RK, Treiber N, Zhang P, Radomska H, Tenen DG et al. Downregulation of c-Jun expression by transcription factor C/EBPalpha is critical for granulocytic lineage commitment. Mol Cell Biol 2002; 22: 8681–8694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Erickson RL, Hemati N, Ross SE, MacDougald OA . p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem 2001; 276: 16348–16355.

    Article  CAS  PubMed  Google Scholar 

  12. Kovacs KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR . CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J Biol Chem 2003; 278: 36959–36965.

    Article  CAS  PubMed  Google Scholar 

  13. Chen CJ, Deng Z, Kim AY, Blobel GA, Lieberman PM . Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol 2001; 21: 476–487.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sapountzi V, Logan IR, Robson CN . Cellular functions of TIP60. Int J Biochem Cell Biol 2006; 38: 1496–1509.

    Article  CAS  PubMed  Google Scholar 

  15. Putnik J, Zhang CD, Archangelo LF, Tizazu B, Bartels S, Kickstein M et al. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. Biochim Biophys Acta 2007; 1772: 1211–1224.

    Article  CAS  PubMed  Google Scholar 

  16. Sarioglu H, Brandner S, Jacobsen C, Meindl T, Schmidt A, Kellermann J et al. Quantitative analysis of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced proteome alterations in 5L rat hepatoma cells using isotope-coded protein labels. Proteomics 2006; 6: 2407–2421.

    Article  CAS  PubMed  Google Scholar 

  17. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6: 308–318.

    Article  CAS  PubMed  Google Scholar 

  18. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S et al. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 2001; 27: 263–270.

    Article  CAS  PubMed  Google Scholar 

  19. Wu FY, Wang SE, Tang QQ, Fujimuro M, Chiou CJ, Zheng Q et al. Cell cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J Virol 2003; 77: 8893–8914.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG . PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 1996; 88: 1234–1247.

    CAS  PubMed  Google Scholar 

  21. Rea S, Xouri G, Akhtar A . Males absent on the first (MOF): from flies to humans. Oncogene 2007; 26: 5385–5394.

    Article  CAS  PubMed  Google Scholar 

  22. Nordentoft I, Jorgensen P . The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor. Biochem J 2003; 374: 165–173.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Troke PJ, Kindle KB, Collins HM, Heery DM . MOZ fusion proteins in acute myeloid leukaemia. Biochem Soc Symp 2006; 73: 23–39.

    Article  CAS  Google Scholar 

  24. Gorrini C, Squatrito M, Luise C, Syed N, Perna D, Wark L et al. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 2007; 448: 1063–1067.

    Article  CAS  PubMed  Google Scholar 

  25. Taubert S, Gorrini C, Frank SR, Parisi T, Fuchs M, Chan HM et al. E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol Cell Biol 2004; 24: 4546–4556.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Johansen LM, Iwama A, Lodie TA, Sasaki K, Felsher DW, Golub TR et al. c-Myc is a critical target for c/EBPalpha in granulopoiesis. Mol Cell Biol 2001; 21: 3789–3806.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 2003; 4: 575–580.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by a scholarship of the Deutsche José Carreras Leukämie-Stiftung e.V. to DB, and by BMBF grants to GB (NGFN2: WP3-SP14) and SKB (NGFN2: WP3-SP11).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S K Bohlander or G Behre.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bararia, D., Trivedi, A., Zada, A. et al. Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα. Leukemia 22, 800–807 (2008). https://doi.org/10.1038/sj.leu.2405101

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405101

Keywords

This article is cited by

Search

Quick links